This is because in addition to reducing and controlling appetite, it also stimulates another hormone, GIP, which is thought to improve how the body breaks down sugar and fat
From their identification as incretin hormones to development of long-acting analogue, GLP-1 agonists have revolutionized metabolic disease management
Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Bhm M, BrunnerLa Rocca HP, Choi DJ, Chopra V, Chuquiure-Valenzuela E, Giannetti N, Gomez-Mesa JE, Janssens S, Januzzi JL, Gonzalez-Juanatey JR, Merkely B, Nicholls SJ, Perrone SV, Pia IL, Packer M
In theory, this could mean: Strong appetite control Better fat-loss signaling Improved recovery Help preserving lean mass during weight loss IMPORTANT: This combo involves prescription-only and in some cases experimental medications